SIETES :: 91969 citas

Resultados de la búsqueda por NÁUSEAS REFINAR BÚSQUEDA

1.

Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]

2.

Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]

3.

DREAMS Trial Collaborators and West Midlands Research Collaborative. Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial). BMJ 2017;357:j1455. [Ref.ID 101540]

4.

Anónimo. FDA approves drug for pregnancy-related nausea and vomiting. DIA Daily 2016:2. [Ref.ID 100938]

5.

Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, Lafky JM, Loprinzi CL. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 2016;375:134-42. [Ref.ID 100630]

6.

Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]

7.

Anónimo. FDA approves first dronabinol solution for oral use. FDA U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]

8.

Pasina L, Zanotta D, Puricelli S, Bonoldi G. Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series. Eur J Clin Pharmacol 2016;72:641-3. [Ref.ID 100252]

9.

Carstairs S. Ondansetron use in pregnancy and birth defects: A systematic review. Obstet Gynecol 2016;127:878-83. [Ref.ID 100204]

10.

Jaspers L, Feys F, Franco OH, Leusink P, Laan ETM. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women. A systematic review and meta-analysis. JAMA Intern Med 2016;176:453-62. [Ref.ID 100072]

11.

Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin. Even the score does not add up . JAMA Intern Med 2016;176:439-42. [Ref.ID 100071]

12.

Voelker R. New pancreatic cancer drug. JAMA 2015;314:2227. [Ref.ID 99728]

13.

Anónimo. FDA approves drug to treat multiple myeloma. DIA Daily 2015:17 de noviembre. [Ref.ID 99644]

14.

Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Ahrén B, Torffvit O, Attvall S, Ekelun M, Filipsson K, Tengmark B-O, Sjöberg S, Pehrsson N-G. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial). BMJ 2015;351:h5364. [Ref.ID 99640]

15.

Kelley KJ. Oral hyperkalemia drug approved. Journal Watch 2015:23 de octubre. [Ref.ID 99572]

16.

Anónimo. Netupitant/palonosetron (Akynzeo) for chemotherapy-induced nausea. Med Lett Drugs Ther 2015;57:61-3. [Ref.ID 99448]

17.

Anónimo. FDA approves new drug treatment for nausea and vomiting from chemotherapy. FDA U.S. Food and Drug Administration 2015:2 de septiembre. [Ref.ID 99434]

18.

Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 2015;313:2474-83. [Ref.ID 99309]

19.

Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S D, Schmidikofer S, Westwood M, Kleijnen J. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313:2456-73. [Ref.ID 99308]

20.

Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]